News Detail
Mumbai, 8 Feb 2024: A few months ago, India’s drug regulator Central Drugs Standard Control Organisation (CDSCO), approved the commercial use of CAR-T cell therapy. The therapy includes genetically reprogramming a patient’s immune system to fight cancer.
......
View Details
Source : Wion
India news
CAR-T cell therapy
cancer news
cancer
Related News
- Centre plans to establish national regulatory framework for AYUSH: Union Minister Jadhav (18-01-2025)
- Smuggler arrested with 1000 Phensedyl cough syrup bottles, handed over to police (18-01-2025)
- STF of Bengal Police seized consignment of banned Phensedyl cough syrup worth Rs 1.5 crore (18-01-2025)
- DGFT issues new SOP for voluntary disclosure of SCOMET violations (18-01-2025)
- Private bodies providing essential services must fall under RTI Act: CIC (18-01-2025)
- 'In-Depth' Probe in Anaesthesia Drugs Complication Cases in Kashmir (18-01-2025)
- Guidelines to tackle Antimicrobial Resistance with Better Testing Machines (18-01-2025)
- IBM and L’Oreal to use gen AI model for sustainable cosmetic formulation (17-01-2025)
- Medical devices sector shows promising growth (17-01-2025)
- Nichlaul: Police arrested for running shop without license for 12 years (17-01-2025)